Observational Study of Blinatumomab

Clinical trial NCT03117621 · COMPLETED

Trial details

NCT number: NCT03117621
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Blincyto Use in Routine Clinical Practice

Start date: 2017-03-22
Primary completion: 2024-03-20
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.